Ginkgo Bioworks Holdings (DNA) Amortization of Goodwill (2024)
Ginkgo Bioworks Holdings posted quarterly Amortization of Goodwill of -$42000.0 for Q4 2024, down 100.09% on a QoQ basis from $47.9 million in Q2 2024.
Ginkgo Bioworks Holdings (DNA) has 1 years of Amortization of Goodwill data on file, last reported at -$42000.0 in Q4 2024.
- For the quarter ending Q4 2024, Amortization of Goodwill changed N/A year-over-year to -$42000.0; the trailing twelve-month figure through Dec 2025 stood at -$42000.0 (down 100.09% YoY), and the FY2024 full-year result was $47.9 million, changed N/A from the prior year.
- Amortization of Goodwill for Q4 2024 stood at -$42000.0, down from $47.9 million in the prior quarter.
- Across five years, Amortization of Goodwill topped out at $47.9 million in Q2 2024 and bottomed at -$42000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ginkgo Bioworks Holdings | 542.03 Mn | 542.03 Mn | 16.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -42,000.00 |
| Dec 31, 2024 | -42,000.00 |
| Jun 30, 2024 | 47.90 Mn |
| Jun 30, 2024 | 47.90 Mn |